Adverse reactions of atezolizumab versus durvalumab based on OpenFDA

<b>Objective</b> To analyze the adverse drug reactions (ADR) of atezolizumab and durvalumab based on the US Food and Drug Administration Public Data Open Project (OpenFDA) to provide reference for rational clinical use of drugs. <b>Methods</b> The ADR data of atezolizumab and...

Full description

Bibliographic Details
Main Authors: LU Xinglan, ZHAO Feng, ZHOU Qiuyun, WANG Fang, LU Tao
Format: Article
Language:zho
Published: The Editorial Department of Chinese Journal of Clinical Research 2023-09-01
Series:Zhongguo linchuang yanjiu
Subjects:
Online Access:http://zglcyj.ijournals.cn/zglcyj/ch/reader/view_abstract.aspx?file_no=20230922&flag=1